Jones Financial Companies Lllp Ab Cellera Biologics Inc. Transaction History
Jones Financial Companies Lllp
- $97.4 Billion
- Q3 2024
A detailed history of Jones Financial Companies Lllp transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 925 shares of ABCL stock, worth $2,701. This represents 0.0% of its overall portfolio holdings.
Number of Shares
925
Previous 3,281
71.81%
Holding current value
$2,701
Previous $9,000
77.78%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ABCL
# of Institutions
154Shares Held
109MCall Options Held
153KPut Options Held
194K-
Baker Bros. Advisors LP New York, NY27.5MShares$80.4 Million0.76% of portfolio
-
Baillie Gifford & CO12.9MShares$37.7 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$31 Million0.03% of portfolio
-
Prosight Management, LP Dallas, TX9.08MShares$26.5 Million6.31% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL4.59MShares$13.4 Million0.0% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $833M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...